Charles & Colvard(CTHR)

Search documents
Charles & Colvard(CTHR) - 2021 Q4 - Annual Report
2021-09-02 16:00
Part I [Business](index=5&type=section&id=Item%201.%20Business) Charles & Colvard is a fine jewelry company specializing in lab-created gemstones, operating through Online and Traditional sales channels - The company's core business is manufacturing, marketing, and distributing lab-created gemstones, including its proprietary **Charles & Colvard Created Moissanite®** and the **Caydia® brand of lab-grown diamonds**, launched in September 2020[18](index=18&type=chunk) - Business operations are divided into two main segments: the **Online Channels segment** (direct-to-consumer websites like charlesandcolvard.com, marketplaces) and the **Traditional segment** (wholesale distributors and retail partners)[22](index=22&type=chunk) - A key strategic dependency is the exclusive supply agreement with Cree, Inc for silicon carbide (SiC) crystals, the raw material for moissanite, extending through June 2025 with a total purchase commitment of approximately **$52.95 million**[70](index=70&type=chunk)[71](index=71&type=chunk) - Strategic goals for Fiscal 2022 include expanding brand presence globally, enhancing customer engagement, developing new products, and pursuing disciplined growth[29](index=29&type=chunk)[33](index=33&type=chunk)[34](index=34&type=chunk)[35](index=35&type=chunk) [Products](index=12&type=section&id=Item%201.%20Business%20-%20Products) The company's product portfolio is led by its premium Forever One™ moissanite and the Caydia® brand of lab-grown diamonds - The company's premier moissanite product is **Forever One™**, a colorless (D-E-F) to near-colorless (G-H-I) gemstone, complemented by a value-oriented line, Moissanite by Charles & Colvard®[64](index=64&type=chunk)[65](index=65&type=chunk) - In September 2020, the company launched **Caydia®**, an exclusive brand of premium lab-grown diamonds available in E, F, and G color grades with a minimum VS1 clarity[73](index=73&type=chunk) Physical Properties of Moissanite vs. Other Gemstones | Description | Refractive Index | Dispersion | Hardness (Mohs) | Toughness | | :--- | :--- | :--- | :--- | :--- | | **Charles & Colvard Created Moissanite®** | 2.65-2.69 | 0.104 | 9.25 – 9.5 | Excellent | | **Diamond (mined and lab grown)** | 2.42 | 0.044 | 10 | Good to Excellent | | **Ruby** | 1.77 | 0.018 | 9 | Excellent | | **Sapphire** | 1.77 | 0.018 | 9 | Excellent | | **Emerald** | 1.58 | 0.014 | 7.50 | Poor to Good | [Distribution Channels](index=7&type=section&id=Item%201.%20Business%20-%20Distribution%20Channels) Sales are conducted through a dual-channel strategy, encompassing direct-to-consumer online platforms and traditional wholesale partners - **Online Channels Segment**: This segment includes direct-to-consumer sales via `charlesandcolvard.com`, marketplaces like Amazon, pure-play e-tailers, and drop-ship arrangements[39](index=39&type=chunk)[40](index=40&type=chunk)[42](index=42&type=chunk)[45](index=45&type=chunk) - **Traditional Segment**: This legacy segment includes sales to manufacturers, distributors, and brick-and-mortar retailers, both domestically and internationally[46](index=46&type=chunk)[49](index=49&type=chunk)[50](index=50&type=chunk) [Competition](index=17&type=section&id=Item%201.%20Business%20-%20Competition) The company faces competition from other moissanite producers, the lab-grown diamond market, and established jewelry brands - The company faces competition from other moissanite producers, primarily from Far Eastern countries, which tend to be of lower quality and compete on price[117](index=117&type=chunk)[119](index=119&type=chunk) - The **lab-grown diamond market** is a significant competitive space, and the company's own Caydia® line could potentially cannibalize sales of its core moissanite products[121](index=121&type=chunk)[122](index=122&type=chunk) - In the finished jewelry space, competitors include well-known brands like **James Allen® and Blue Nile Inc**, which have strong brand recognition and greater financial resources[126](index=126&type=chunk) [Risk Factors](index=23&type=section&id=Item%201A.%20Risk%20Factors) The company faces operational risks from the COVID-19 pandemic, supplier dependency, and intense competition, alongside financial and stock listing risks - **COVID-19 Pandemic**: The pandemic continues to pose risks by affecting workforces, supply chains, and consumer demand, with the full future impact remaining uncertain[140](index=140&type=chunk)[146](index=146&type=chunk) - **Supplier Dependency**: The company depends on an exclusive supply agreement with **Cree, Inc** for substantially all of its silicon carbide (SiC) crystals, and any interruption could materially harm the business[178](index=178&type=chunk) - **Competition**: The company faces intense competition from other moissanite producers, the lab-grown diamond industry, and established jewelry companies, with pressure increasing since its core patents expired[156](index=156&type=chunk)[158](index=158&type=chunk) - **PPP Loan Review**: The company's **$965,000 PPP loan**, though forgiven, remains subject to SBA review for six years, with potential for penalties and repayment[192](index=192&type=chunk)[193](index=193&type=chunk) - **Nasdaq Listing**: The company's common stock could be delisted from The Nasdaq Capital Market if it fails to maintain listing requirements, such as the **minimum $1.00 bid price**[196](index=196&type=chunk) [Properties](index=34&type=section&id=Item%202.%20Properties) The company's operations are centralized in a leased 36,350 square foot facility in Research Triangle Park, North Carolina - The company's principal property is a leased **36,350 sq ft** facility in Research Triangle Park, NC, which serves as its headquarters for all major functions[198](index=198&type=chunk) [Legal Proceedings](index=34&type=section&id=Item%203.%20Legal%20Proceedings) The company is not currently a party to any material pending legal proceedings - There are **no material pending legal proceedings** involving the company[199](index=199&type=chunk) Part II [Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities](index=34&type=section&id=Item%205.%20Market%20for%20Registrant's%20Common%20Equity%2C%20Related%20Stockholder%20Matters%20and%20Issuer%20Purchases%20of%20Equity%20Securities) The company's common stock trades on the Nasdaq Capital Market under the symbol "CTHR" and no dividends were paid in fiscal 2021 or 2020 - The company's common stock trades on The Nasdaq Capital Market under the ticker symbol **"CTHR"**[200](index=200&type=chunk) - **No dividends** were paid on common stock during the fiscal years ended June 30, 2021, and 2020[201](index=201&type=chunk) [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=35&type=section&id=Item%207.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Fiscal year 2021 marked a significant turnaround with a 34% increase in net sales, a return to profitability, and strengthened liquidity [Results of Operations](index=39&type=section&id=Item%207.%20MD%26A%20-%20Results%20of%20Operations) Net sales grew 34% to $39.2 million, driving a shift from a significant net loss in 2020 to a net income of $12.8 million in 2021 - The increase in net sales was driven by robust holiday sales, increased consumer awareness, and strong demand for both moissanite and lab-grown diamond products[234](index=234&type=chunk) - Cost of goods sold **decreased by 2%** despite a 34% increase in sales, primarily due to a **$5.26 million write-off** of legacy inventory in the prior year[242](index=242&type=chunk) - Sales and marketing expenses **decreased by 10% to $8.48 million**, mainly due to lower compensation-related expenses following a 2020 workforce reduction[246](index=246&type=chunk)[247](index=247&type=chunk)[248](index=248&type=chunk) - A significant **income tax benefit of $6.33 million** was recognized in FY 2021, primarily from the release of the valuation allowance against deferred tax assets[262](index=262&type=chunk)[264](index=264&type=chunk) Consolidated Net Sales (Fiscal Year Ended June 30) | Category | 2021 | 2020 | Change ($) | Change (%) | | :--- | :--- | :--- | :--- | :--- | | Finished jewelry | $24,401,546 | $16,777,628 | $7,623,918 | 45% | | Loose jewels | $14,834,293 | $12,411,392 | $2,422,901 | 20% | | **Total Net Sales** | **$39,235,839** | **$29,189,020** | **$10,046,819** | **34%** | Consolidated Statement of Operations Highlights (Fiscal Year Ended June 30) | Metric | 2021 | 2020 | | :--- | :--- | :--- | | Net Sales | $39,235,839 | $29,189,020 | | Cost of Goods Sold | $20,809,690 | $21,200,207 | | Income (Loss) from Operations | $5,507,992 | ($6,315,728) | | Gain on extinguishment of debt | $974,328 | $0 | | Income tax benefit (expense) | $6,332,421 | ($1,733) | | **Net Income (Loss)** | **$12,810,766** | **($6,162,083)** | [Liquidity and Capital Resources](index=45&type=section&id=Item%207.%20MD%26A%20-%20Liquidity%20and%20Capital%20Resources) The company's liquidity improved substantially, with cash increasing to $21.5 million and the full forgiveness of its $965,000 PPP loan - As of June 30, 2021, the company's principal sources of liquidity were cash, cash equivalents, and restricted cash totaling **$21.45 million**, a significant increase from $14.62 million at June 30, 2020[280](index=280&type=chunk) - Working capital **increased by $12.72 million to $30.14 million** in FY 2021, driven by higher cash from operations and the forgiveness of the PPP loan[281](index=281&type=chunk) - The company's **$965,000 PPP loan was forgiven in full** by the SBA on June 23, 2021, resulting in a gain on debt extinguishment of approximately $974,000[271](index=271&type=chunk) - The company has a remaining purchase commitment of approximately **$32.85 million** under its exclusive Supply Agreement with Cree, which extends to June 2025[294](index=294&type=chunk) - Subsequent to year-end, the company secured a new **$5.00 million cash-collateralized line of credit facility** with JPMorgan Chase[297](index=297&type=chunk) [Financial Statements and Supplementary Data](index=55&type=section&id=Item%208.%20Financial%20Statements%20and%20Supplementary%20Data) The audited financial statements received an unqualified opinion, highlighting strong growth in assets, income, and operating cash flow - The report from the independent registered public accounting firm, BDO USA, LLP, expressed an **unqualified opinion** on the consolidated financial statements[338](index=338&type=chunk) - The auditor identified two Critical Audit Matters: the **valuation of inventories** and the **realizability of deferred tax assets**, both requiring significant management judgment[342](index=342&type=chunk)[343](index=343&type=chunk)[347](index=347&type=chunk) Consolidated Balance Sheet Highlights (as of June 30) | Account | 2021 | 2020 | | :--- | :--- | :--- | | Cash, cash equivalents, and restricted cash | $21,446,951 | $14,617,234 | | Total Inventory, net | $29,172,720 | $30,633,959 | | **Total Assets** | **$64,921,999** | **$48,904,587** | | Total Current Liabilities | $5,622,263 | $6,486,060 | | Total Liabilities | $9,232,983 | $7,469,010 | | **Total Shareholders' Equity** | **$55,689,016** | **$41,435,577** | Consolidated Statement of Operations Highlights (Fiscal Year Ended June 30) | Account | 2021 | 2020 | | :--- | :--- | :--- | | Net Sales | $39,235,839 | $29,189,020 | | Net Income (Loss) | $12,810,766 | ($6,162,083) | | Diluted EPS | $0.42 | ($0.22) | Consolidated Statement of Cash Flows Highlights (Fiscal Year Ended June 30) | Account | 2021 | 2020 | | :--- | :--- | :--- | | Net cash provided by operating activities | $6,473,092 | $249,185 | | Net cash used in investing activities | ($733,465) | ($535,976) | | Net cash provided by financing activities | $1,090,090 | $1,897,480 | | **Net increase in cash, cash equivalents, and restricted cash** | **$6,829,717** | **$1,610,689** | [Controls and Procedures](index=87&type=section&id=Item%209A.%20Controls%20and%20Procedures) Management concluded that the company's disclosure controls and internal control over financial reporting were effective as of June 30, 2021 - Based on an evaluation as of June 30, 2021, the Chief Executive Officer and Chief Financial Officer concluded that the company's **disclosure controls and procedures were effective**[518](index=518&type=chunk) - Management's report on internal control over financial reporting concluded that these controls were **effective as of June 30, 2021**, based on the COSO 2013 framework[520](index=520&type=chunk)[524](index=524&type=chunk) - **No material changes** were made to internal control over financial reporting during the quarter ended June 30, 2021[519](index=519&type=chunk) Part III [Directors, Executive Officers, Corporate Governance, Compensation, and Related Matters](index=88&type=section&id=Items%2010-14) Required disclosures for directors, officers, and governance are incorporated by reference from the company's 2021 Proxy Statement - Details regarding directors, executive officers, executive compensation, security ownership, and related transactions are **incorporated by reference** from the forthcoming 2021 Proxy Statement[528](index=528&type=chunk) Part IV [Exhibits, Financial Statement Schedules](index=89&type=section&id=Item%2015.%20Exhibits%2C%20Financial%20Statement%20Schedules) This section lists all exhibits filed with the Form 10-K, including material contracts and required Sarbanes-Oxley certifications - This section provides a comprehensive list of all exhibits filed as part of the Form 10-K, as required by **Item 601 of Regulation S-K**[533](index=533&type=chunk)
Charles & Colvard(CTHR) - 2021 Q3 - Earnings Call Transcript
2021-05-09 08:46
Charles & Colvard, Ltd. (NASDAQ:CTHR) Q3 2021 Earnings Conference Call May 6, 2021 4:30 PM ET Company Participants Don O'Connell - President & Chief Executive Officer Clint Pete - Chief Financial Officer Conference Call Participants Paul Zimnisky - PZDA Eric Landry - BML Capital Jason Ursaner - Bumbershoot Holdings. Operator Good day, and welcome to the Charles & Colvard Third Quarter Fiscal Year 2021 Earnings Conference Call and Webcast. All participants will be in a listen-only mode. [Operator Instruction ...
Charles & Colvard(CTHR) - 2021 Q3 - Earnings Call Presentation
2021-05-08 00:21
Financial Performance - Net sales increased by 45% to $9.4 million compared to the year-ago quarter[5,8] - Loose jewel and finished jewelry net sales increased by 45% to $5.6 million[9] - Net income was $1.0 million, or $0.03 per diluted share[5,15,16] - Cash flow from operations was $2.3 million, with total cash at $19.7 million[5] - Gross margin was 46%[5,14] Segment Performance - Net sales from online channels segment increased by 79% to $6.2 million[10] - Net sales from the traditional segment increased by 7% to $3.2 million[10] Operating Expenses - Total operating expenses decreased by 6% to $3.3 million[14] - Sales & marketing expenses increased by 10% to $1.1 million[14] - General & administrative expenses decreased by 12% to $2.2 million[14] Balance Sheet - Total cash increased to $19.7 million as of March 31, 2021[17] - Inventory decreased to $28.9 million as of March 31, 2021[17] - Total assets increased to $57.4 million as of March 31, 2021[17] - Total liabilities increased to $10.2 million as of March 31, 2021[17]
Charles & Colvard(CTHR) - 2021 Q3 - Quarterly Report
2021-05-06 16:00
[PART I – FINANCIAL INFORMATION](index=4&type=section&id=PART%20I%20%E2%80%93%20FINANCIAL%20INFORMATION) Financial information for the period, including statements, MD&A, market risk, and controls [Financial Statements](index=4&type=section&id=Item%201.%20Financial%20Statements) Presents the company's financial position, operational performance, and cash flows for the quarter ended March 31, 2021 [Condensed Consolidated Balance Sheets](index=4&type=section&id=Condensed%20Consolidated%20Balance%20Sheets) The balance sheet as of March 31, 2021, shows increased assets and equity, reflecting a stronger financial position Condensed Consolidated Balance Sheet Highlights (in thousands) | Account | March 31, 2021 (unaudited) | June 30, 2020 | | :--- | :--- | :--- | | **Assets** | | | | Cash and cash equivalents | $19,609 | $13,993 | | Inventory, net (Total) | $28,946 | $30,634 | | Total current assets | $35,794 | $23,909 | | TOTAL ASSETS | **$57,397** | **$48,905** | | **Liabilities & Equity** | | | | Total current liabilities | $6,133 | $6,486 | | Total liabilities | $10,247 | $7,469 | | Total shareholders' equity | $47,150 | $41,436 | | TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | **$57,397** | **$48,905** | [Condensed Consolidated Statements of Operations](index=5&type=section&id=Condensed%20Consolidated%20Statements%20of%20Operations) Reports a significant turnaround to net income for Q3 and nine months ended March 31, 2021, driven by sales growth Key Operational Metrics (in thousands, except per share data) | Metric | Three Months Ended Mar 31, 2021 | Three Months Ended Mar 31, 2020 | Nine Months Ended Mar 31, 2021 | Nine Months Ended Mar 31, 2020 | | :--- | :--- | :--- | :--- | :--- | | Net sales | $9,436 | $6,491 | $29,509 | $24,759 | | Cost of goods sold | $5,093 | $9,172 | $15,457 | $18,579 | | Income (Loss) from operations | $1,039 | $(6,194) | $4,434 | $(5,277) | | Net income (loss) | **$1,036** | **$(6,155)** | **$4,430** | **$(5,134)** | | Diluted EPS | **$0.03** | **$(0.21)** | **$0.15** | **$(0.18)** | [Condensed Consolidated Statements of Cash Flows](index=7&type=section&id=Condensed%20Consolidated%20Statements%20of%20Cash%20Flows) Cash flow from operations turned positive for the nine months ended March 31, 2021, significantly increasing cash Cash Flow Summary (Nine Months Ended March 31, in thousands) | Cash Flow Category | 2021 | 2020 | | :--- | :--- | :--- | | Net cash provided by (used in) operating activities | **$4,668** | $(1,572) | | Net cash used in investing activities | $(622) | $(466) | | Net cash provided by financing activities | $1,013 | $932 | | **Net increase (decrease) in cash** | **$5,058** | **$(1,105)** | [Notes to Condensed Consolidated Financial Statements](index=8&type=section&id=Notes%20to%20Condensed%20Consolidated%20Financial%20Statements) Provides detailed disclosures on business segments, accounting policies, supply agreements, and the PPP loan - The company manufactures and distributes Charles & Colvard Created Moissanite® and Caydia™ lab grown diamonds, selling loose jewels and finished jewelry through both wholesale (Traditional) and direct-to-consumer e-commerce (Online Channels) segments[24](index=24&type=chunk) Segment Net Sales (Three Months Ended March 31, 2021) | Segment | Finished Jewelry | Loose Jewels | Total Net Sales | | :--- | :--- | :--- | :--- | | Online Channels | $4,902,964 | $680,804 | **$5,583,768** | | Traditional | $1,316,928 | $2,535,360 | **$3,852,288** | | **Total** | **$6,219,892** | **$3,216,164** | **$9,436,056** | - The company has an exclusive supply agreement with Cree, Inc. for SiC materials, with a total purchase commitment of approximately **$52.95 million** extending to June 2025. As of March 31, 2021, approximately **$34.35 million** of this commitment remains[76](index=76&type=chunk)[77](index=77&type=chunk) - The company received a **$965,000** loan under the Paycheck Protection Program (PPP) in June 2020, which is accounted for as debt. As of March 31, 2021, the full amount remains outstanding[85](index=85&type=chunk)[87](index=87&type=chunk) [Management's Discussion and Analysis of Financial Condition and Results of Operations (MD&A)](index=24&type=section&id=Item%202.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management discusses the drivers behind the improved financial performance and the company's liquidity position [Results of Operations](index=28&type=section&id=Results%20of%20Operations) Analyzes the **45% increase** in net sales and the factors influencing cost of goods sold and operating expenses Consolidated Net Sales Breakdown (Three Months Ended March 31) | Product Line | 2021 | 2020 | Change ($) | Change (%) | | :--- | :--- | :--- | :--- | :--- | | Finished jewelry | $6,219,892 | $3,480,168 | $2,739,724 | **79%** | | Loose jewels | $3,216,164 | $3,010,880 | $205,284 | **7%** | | **Total** | **$9,436,056** | **$6,491,048** | **$2,945,008** | **45%** | - The decrease in cost of goods sold for Q3 2021 was primarily driven by a prior year write-off of approximately **$5.26 million** related to legacy loose jewel and finished goods inventory during the quarter ended March 31, 2020[144](index=144&type=chunk) - Sales and marketing expenses for Q3 2021 decreased by **12%** YoY, mainly due to a **$261,000** reduction in compensation-related expenses following a June 2020 management reorganization and workforce reduction[149](index=149&type=chunk)[150](index=150&type=chunk)[151](index=151&type=chunk) [Liquidity and Capital Resources](index=34&type=section&id=Liquidity%20and%20Capital%20Resources) Details the company's cash position, working capital, and significant financial commitments and credit facilities - As of March 31, 2021, the company's principal sources of liquidity were cash and equivalents of **$19.7 million** and access to a **$5.0 million** asset-based revolving credit facility, which was undrawn[181](index=181&type=chunk)[195](index=195&type=chunk) - The company has a long-term debt of **$965,000** from a PPP loan received in June 2020. Monthly payments are scheduled to commence on October 1, 2021[171](index=171&type=chunk)[178](index=178&type=chunk) - A significant contractual commitment exists with Cree, Inc. for the exclusive supply of SiC materials. The total commitment is approximately **$52.95 million** through June 2025, with a remaining balance of **$34.35 million** as of March 31, 2021[190](index=190&type=chunk) [Quantitative and Qualitative Disclosures About Market Risk](index=38&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) This section is not applicable for the company as it qualifies as a smaller reporting company - The company has indicated that quantitative and qualitative disclosures about market risk are not applicable[199](index=199&type=chunk) [Controls and Procedures](index=38&type=section&id=Item%204.%20Controls%20and%20Procedures) Management confirmed the effectiveness of disclosure controls and procedures with no material changes to internal controls - Based on an evaluation as of the end of the period, the Chief Executive Officer and Chief Financial Officer concluded that the company's disclosure controls and procedures were effective at a reasonable assurance level[200](index=200&type=chunk) - No changes were made to the internal control over financial reporting during the three months ended March 31, 2021, that materially affected, or are reasonably likely to materially affect, these controls[201](index=201&type=chunk) [PART II – OTHER INFORMATION](index=39&type=section&id=PART%20II%20%E2%80%93%20OTHER%20INFORMATION) Other information including legal proceedings, risk factors, and exhibits filed with the report [Legal Proceedings](index=39&type=section&id=Item%201.%20Legal%20Proceedings) The company reports no material pending legal proceedings as of the reporting date - There are no material pending legal proceedings involving the company[204](index=204&type=chunk) [Risk Factors](index=39&type=section&id=Item%201A.%20Risk%20Factors) No material changes to previously disclosed risk factors were reported for the period - There have been no material changes to the risk factors disclosed in previous reports[205](index=205&type=chunk) [Exhibits](index=40&type=section&id=Item%206.%20Exhibits) Lists the certifications by executive officers and XBRL financial data filed as exhibits - Exhibits filed include certifications by the CEO and CFO under Sections 302 and 906 of the Sarbanes-Oxley Act, and financial statements formatted in XBRL[207](index=207&type=chunk)
Charles & Colvard(CTHR) - 2021 Q2 - Earnings Call Presentation
2021-02-05 20:54
Nasdaq: CTHR 1 CHARLES & COLVARD Q2 Fiscal 2021 Earnings Conference Call Presentation Forward Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements expressing expectations regarding our future and projections relating to our products, sales, revenues, and earnings are typical of such statements and are made under the Private Securities ...
Charles & Colvard(CTHR) - 2021 Q2 - Earnings Call Transcript
2021-02-05 02:35
Charles & Colvard, Ltd. (NASDAQ:CTHR) Q2 2021 Earnings Conference Call February 4, 2021 4:30 PM ET Company Participants Don O'Connell – President and Chief Executive Officer Clint Pete – Chief Financial Officer Conference Call Participants Matt Koranda – ROTH Capital Jason Ursaner – Bumbershoot Holdings Paul Zimnisky – PZDA Eric Landry – BML Capital Operator Good day, and welcome to the Charles & Colvard Second Quarter Fiscal Year 2021 Earnings Conference Call and Webcast. All participants will be in a list ...
Charles & Colvard(CTHR) - 2021 Q2 - Quarterly Report
2021-02-03 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, no par value per share CTHR The Nasdaq Stock Market LLC FORM 10-Q (Mark One) ☒ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended December 31, 2020 OR ☐ Transition report pursuant to Section 13 of 15(d) of the Securities Exchange Act of 1934 For the transition period from _____ ...
Charles & Colvard(CTHR) - 2021 Q1 - Earnings Call Presentation
2020-11-06 14:09
1 Conference Call Presentation Nasdaq: CTHR Q1 Fiscal 2021 Earnings Forward Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements expressing expectations regarding our future and projections relating to our products, sales, revenues, and earnings are typical of such statements and are made under the Private Securities Litigation Reform ...
Charles & Colvard(CTHR) - 2021 Q1 - Quarterly Report
2020-11-05 22:51
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, no par value per share CTHR The Nasdaq Stock Market LLC FORM 10-Q (Mark One) ☒ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended September 30, 2020 OR ☐ Transition report pursuant to Section 13 of 15(d) of the Securities Exchange Act of 1934 For the transition period from ____ ...
Charles & Colvard(CTHR) - 2020 Q4 - Earnings Call Transcript
2020-09-03 22:23
Charles & Colvard, Ltd. (NASDAQ:CTHR) Q4 2020 Earnings Conference Call September 3, 2020 4:30 PM ET Company Participants Don O'Connell - President & Chief Executive Officer Clint Pete - Chief Financial Officer Conference Call Participants Gustavo Gala - ROTH Capital Partners Berke Bakay - Bakay Capital Management Adam Proger - Raymond James Operator Good day, and welcome to the Charles & Colvard Q4 Fiscal Year 2020 Earnings Call. All participants will be in listen-only mode. [Operator Instructions] After to ...